MTOR and prostate carcinoma: Chang et al. (https://www.ncbi.nlm.nih.gov/pubmed/24157869/) found that the radiation resistance of prostate cancer was related to the enhanced CSC phenotype through the activation of the PI3K/AKT/mTOR signaling pathway (Chang et al., 2013).